tiprankstipranks
Trending News
More News >
ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market

ImmunoCellular Therapeutics (IMUC) Cash flow

Compare
184 Followers

ImmunoCellular Therapeutics Cash Flow

IMUC's free cash flow for Q4 2022 was $-687.93K. For the 2022 fiscal year, IMUC's free cash flow was decreased by $-1.26M and operating cash flow was $-687.93K. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -2.68M$ -1.42M$ -2.62M$ -2.31M$ -1.24M
Investing Cash Flow
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ 2.50M$ 1.09M$ 1.75M$ 3.53M$ 1.50M
End Cash Position
$ 98.67K$ 278.26K$ 613.24K$ 1.49M$ 262.98K
Free Cash Flow
$ -2.68M$ -1.42M$ -2.62M$ -2.31M$ -1.24M
Currency in USD

ImmunoCellular Therapeutics Cash Flow